Minimally Invasive Biopsy Technologies Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028
The Global Minimally
Invasive Biopsy Technologies Market is projected to reach
USD 3.98 billion in 2027. The market is expected to be driven due to a higher
proliferation of the minimally invasive surgical procedures in biopsy testing
and an extensive rise in the rate of breast and lung cancers globally. Around
66% of the total initial breast biopsies performed in North America are
minimally invasive breast biopsies (MIBB).
The report provides Minimally Invasive Biopsy Technologies market
forecast, supported by detailed insights historical data and revenues, past and
current market trends, industry trends, consumer trends, market size, market
share, market growth, along with ranging impacts of each factor and driver. It
also provides analysis of various factors expected to restrain or limit
potential growth in market size over the forecast period, 2020–2028. The report
includes profiles of major players in the market, strategies being employed,
mergers, acquisitions, recent developments, agreements, contracts, new product
development and launches, segment revenue, investment details as well as
financials.
Download FREE Sample Brochure (Customized Sample PDF File
delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/75
Global Minimally Invasive Biopsy Technologies market forecast has
been provided following thorough study, focus, comparison, and analysis of a
varying range of factors and past market forecast and present outcomes.
Minimally Invasive Biopsy Technologies Market forecast is made possible
through, but has not been limited to, a study and analysis of a variety of
factors and trends, and these are verified through interviews with industry
experts and companies operating in the market.
Rising focus by major companies on product/service expansion into
new and untapped domestic markets, increasing investments in strategic
agreements, favourable government policies and regulations, and growing
competition in the market are some major trends observed in the Minimally
Invasive Biopsy Technologies market. Development of more advanced offerings is
driving rising demand and deployment in respective sectors/industries, and this
is expected to drive Minimally Invasive Biopsy Technologies market revenue
growth to a significant extent over the forecast period.
Top key vendors in Minimally Invasive Biopsy Technologies Market
include are:
- Key players in
the market include Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche
Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific,
NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies,
and Owlstone Medical Ltd., among others.
On the basis of the end users/applications, this report focuses on
the status and outlook for major applications/end users, consumption (sales),
market share and growth rate for each application, including
For the purpose of this report, Emergen Research has segmented
into the global Minimally Invasive Biopsy Technologies Market on the basis of Technology,
Therapeutic Application, End-Use Verticals, and region:
- Technology
Outlook (Revenue: USD Billion; 2017-2027)
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented
Lesion Assays
- Breath Biopsy
- Brush Biopsy
- Others
- Therapeutic
Application Outlook (Revenue: USD Billion; 2017-2027)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal
Cancer
- Blood Cancer
- Non-oncology
Applications
- End-Use
Verticals Outlook (Revenue: USD Billion; 2017-2027)
- Hospitals &
Clinics
- Ambulatory
Surgical Centers
- Cancer Research
Institutes
- Others
Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market
Incorporated with Info-graphics, charts, 70 tables and 85 figures,
this 250-page research report “Minimally Invasive Biopsy Technologies Market
Size, Type, Application, End-Use Industry, Regional Outlook, Competitive
Strategies and Forecasts, 2020 - 2027” is based on a complete research of the
entire Global market and covering all its sub-segments through comprehensively
thorough classifications. Insightful analysis and assessment are created from
superior primary and secondary information sources with data and information
derived from industry specialists across the value chain.
Region wise performance of the Minimally Invasive Biopsy
Technologies industry
North America Minimally Invasive Biopsy Technologies market
forecast is expected to remain significantly positive in terms of revenue share
between 2020 and 2028. In addition, North America Minimally Invasive Biopsy
Technologies market revenue share is expected to remain comparatively larger
than that of other regional markets from 2020 to 2028.
Asia Pacific registered fastest revenue CAGR in 2020, and the
Minimally Invasive Biopsy Technologies market forecast is that this trend is
expected to continue going ahead. Market forecast states that revenue share
contribution from China, India, and South Korea is expected to remain robust
till 2028.
Europe Minimally Invasive Biopsy Technologies market forecast is
positive currently, with revenue growth expected to remain steady between 2020
and 2028. Robust focus on research and development initiatives by major firms
and changing trends and demographics in countries in the region are some
factors expected to continue to support Minimally Invasive Biopsy Technologies
market growth.
Geographically, this report studies the key regions, focuses on
product sales, value, market share and growth opportunity in these regions,
covering:
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
We can also provide the customized separate regional or
country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China,
India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of
Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of
Europe, Central & South America, Brazil, Argentina, Rest of South America,
Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East &
Africa
Request customized copy of Minimally Invasive Biopsy Technologies
report@ https://www.emergenresearch.com/request-for-customization/75
The research provides answers to the following key questions:
- What will be the
growth rate and the market size of the Minimally Invasive Biopsy
Technologies industry for the forecast period 2020-2027?
- What are the
major driving forces expected to impact the development of the Minimally
Invasive Biopsy Technologies market across different regions?
- Who are the
major driving forces expected to decide the fate of the Minimally Invasive
Biopsy Technologies industry worldwide?
- Who are the
prominent market players making a mark in the Minimally Invasive Biopsy
Technologies market with their winning strategies?
- Which Minimally
Invasive Biopsy Technologies industry trends are likely to shape the
future of the industry during the forecast period 2020-2027?
- What are the key
barriers and threats believed to hinder the development of the industry?
- What are the
future opportunities in the Minimally Invasive Biopsy Technologies market?
Table of Content
Chapter 1. Methodology & Sources
1.1. Minimally Invasive Biopsy Technologies
Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1.
Primary
1.4.2.
Secondary
1.4.3. Paid
Sources
1.5. Minimally Invasive Biopsy Technologies
Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Minimally Invasive Biopsy Technologies Market
Segmentation & Impact Analysis
4.1. Minimally Invasive Biopsy Technologies
Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1.
Minimally Invasive Biopsy Technologies Market indicators analysis
4.2.2.
Minimally Invasive Biopsy Technologies Market drivers analysis
4.2.2.1. Rapid urbanization and industrialization
4.2.2.2. Stringent government regulations regarding carbon emissions
4.2.2.3. Increasing prevalence of respiratory diseases
4.2.2.4. Rising need to enhance indoor air quality
4.2.3.
Minimally Invasive Biopsy Technologies Market restraints analysis
4.2.3.1. High cost associated with the maintenance of Minimally Invasive Biopsy
Technologies products
4.2.3.2. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 10. Competitive Landscape
10.1. Minimally Invasive Biopsy Technologies
Market Revenue Share By Manufacturers
10.2. Mergers & Acquisitions
10.3. Competitor’s Positioning
10.4. Strategy Benchmarking
10.5. Vendor Landscape
10.5.1. Raw
Material Suppliers
10.5.1.1. North America
10.5.1.2. Europe
10.5.1.3. Asia Pacific
10.5.1.4. Middle East & Africa
10.5.1.5. Latin America
10.5.2.
Distributors
10.5.2.1. North America
10.5.2.2. Europe
10.5.2.3. Asia Pacific
10.5.2.4. Middle East & Africa
10.5.2.5. Latin America
10.5.3.
Others
Continued….
Avail Discount on Minimally Invasive Biopsy Technologies Market
Report@ https://www.emergenresearch.com/request-discount/75
Why Choose Emergen Research?
1.
Strong Industry Focus
2.
Extensive Product Offerings
3.
Customer Research Services
4.
Robust Research Methodology
5.
Comprehensive Reports
6.
Latest Technological Developments
7.
Value Chain Analysis
8.
Potential Market Opportunities
9.
Growth Dynamics
10.
Quality Assurance
11.
Post-sales Support
Read similar reports by Emergen Research:
Blockchain
Supply Chain Market
Carbon
Neutral Data Center Market
Non-Volatile
Memory Express Market
Green
Technology and Sustainability Market
Hemodynamic
Monitoring Devices Market
Healthcare
Distribution Market
Comments
Post a Comment